Pexidartinib(PLX-3397) is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
- Country: China (Mainland)
- Market: European Union,Americas
- Founded Year: 2009
- Address: 武汉东湖高新区长城科技园光谷精工D栋402室
- Contact: Rosie Liu